Literature DB >> 14990601

Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?

I S Cook1, C E Fuller.   

Abstract

AIM: To assess the value of the histopathological examination of routine breast reduction specimens.
METHODS: All patients who underwent breast reduction surgery over a 10 year period were identified. The histopathology report for each patient was analysed. For all cases with important microscopic abnormalities, the patient's medical notes were examined to identify whether clinical follow up was arranged.
RESULTS: Histopathology reports for specimens from 1289 patients were examined. One thousand, two hundred and fifty eight of these specimens (97.6%) were reported microscopically as showing normal breast tissue or benign breast disease, 26 cases (2.0%) showed lesions of uncertain malignant potential, four cases (0.3%) showed ductal carcinoma in situ (DCIS) or microinvasive malignancy, and there was one case (0.1%) of invasive malignancy. Important diagnoses were made in 2.1% of cases with no macroscopic abnormality. Clinical follow up was arranged for all patients with a diagnosis of DCIS, microinvasive carcinoma, or invasive malignancy. There were 26 patients diagnosed with lesions of uncertain malignant potential; 11 had follow up arrangements made and 13 patients were discharged. Follow up data was not available for two patients.
CONCLUSIONS: Histopathological examination of breast reduction specimens may reveal important pathological diagnoses. In some cases, patients were discharged from medical care despite histopathological examination revealing lesions associated with an increased risk of developing breast carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 14990601      PMCID: PMC1770254          DOI: 10.1136/jcp.2003.012427

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Statistical study of malignancies found before, during, or after routine breast plastic operations.

Authors:  R K SNYDERMAN; J G LIZARDO
Journal:  Plast Reconstr Surg Transplant Bull       Date:  1960-03

2.  Breast cancer in reduction mammoplasty: case reports and a survey of plastic surgeons.

Authors:  D A Jansen; M Murphy; G M Kind; K Sands
Journal:  Plast Reconstr Surg       Date:  1998-02       Impact factor: 4.730

Review 3.  The transition from hyperplasia to invasive carcinoma of the breast.

Authors:  S R Lakhani
Journal:  J Pathol       Date:  1999-02       Impact factor: 7.996

Review 4.  The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention.

Authors:  R M Simmons; M P Osborne
Journal:  Surg Oncol       Date:  1999-08       Impact factor: 3.279

Review 5.  Evaluation and management of high risk and premalignant lesions of the breast.

Authors:  D L Page; R A Jensen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

6.  A prospective study of benign breast disease and the risk of breast cancer.

Authors:  S J London; J L Connolly; S J Schnitt; G A Colditz
Journal:  JAMA       Date:  1992-02-19       Impact factor: 56.272

Review 7.  Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?

Authors:  Timothy W Jacobs; James L Connolly; Stuart J Schnitt
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

8.  Premalignant conditions and markers of elevated risk in the breast and their management.

Authors:  D L Page; W D Dupont
Journal:  Surg Clin North Am       Date:  1990-08       Impact factor: 2.741

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases.

Authors:  S Ciatto; C Andreoli; A Cirillo; R Bonardi; S Bianchi; G Santoro; G Farante; A Magni; T Campa; A Costa
Journal:  Tumori       Date:  1991-02-28
View more
  8 in total

1.  Mammoplasty for symmetry in breast reconstruction and histologic assessment.

Authors:  Apollinaire Gninlgninrin Horo; Olivier Acker; Etienne Roussel; Henri Marret; Gilles Body
Journal:  Can J Surg       Date:  2011-06       Impact factor: 2.089

2.  Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.

Authors:  Pedro Luiz Serrano Usón Junior; Donato Callegaro Filho; Diogo Diniz Gomes Bugano; Felipe Correa Geyer; Marcus Vinicius de Nigro Corpa; Paulo David Scatena Gonçalves; Sergio Daniel Simon; Rafael Aliosha Kaliks
Journal:  Pathol Oncol Res       Date:  2017-04-08       Impact factor: 3.201

3.  Pathology Examination of Breast Reduction Specimens: Dispelling the Myth.

Authors:  Mark Fisher; Aaron L Burshtein; Joshua G Burshtein; Panagiotis Manolas; Scot B Glasberg
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-11-24

4.  The management of incidental findings of reduction mammoplasty specimens.

Authors:  Jessica T Goodwin; Chantelle Decroff; Emilia Dauway; Amelia Sybenga; Raman C Mahabir
Journal:  Can J Plast Surg       Date:  2013

5.  Radiologically innocuous breast reduction specimens. Should we send them to pathology lab anyway?

Authors:  B Celik; D Senen Demiroz; M Yaz; U Muslu
Journal:  G Chir       Date:  2013 Nov-Dec

6.  Histopathological evaluation of reduction mammaplasty specimens to detect occult breast cancer: a report from southern iran.

Authors:  Mohammad Hossain Rajabian; Perikala Vijayananda Kumar
Journal:  World J Plast Surg       Date:  2012-07

7.  Atypical Hyperplasia Found Incidentally during Routine Breast Reduction Mammoplasty: Incidence and Management.

Authors:  Seth Noorbakhsh; Zachary A Koenig; Noah Hewitt; Mihail Climov; Hannah Hazard-Jenkins; Melina Flanagan; Kerri Woodberry
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-22

8.  Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients.

Authors:  M Tadler; G Vlastos; M-F Pelte; J-C Tille; C Bouchardy; M Usel; B Pittet-Cuénod; A Modarressi
Journal:  Br J Cancer       Date:  2013-11-14       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.